These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 32791233)

  • 21. The presence of lepidic and micropapillary/solid pathological patterns as minor components has prognostic value in patients with intermediate-grade invasive lung adenocarcinoma.
    Hou Y; Song W; Chen M; Zhang J; Luo Q; Um SW; Facchinetti F; Bongiolatti S; Zhou Q
    Transl Lung Cancer Res; 2022 Jan; 11(1):64-74. PubMed ID: 35242628
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Correlation between epidermal growth factor receptor mutation and histologic subtypes or characteristics of computed tomography findings in patients with resected pulmonary adenocarcinoma.
    Wang D; Yan N; Yang X; Ge Y; Xu D; Shao G; Peng Z
    J Cancer Res Ther; 2018 Jan; 14(1):240-244. PubMed ID: 29516992
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CT-based Radiogenomic Analysis of Clinical Stage I Lung Adenocarcinoma with Histopathologic Features and Oncologic Outcomes.
    Perez-Johnston R; Araujo-Filho JA; Connolly JG; Caso R; Whiting K; Tan KS; Zhou J; Gibbs P; Rekhtman N; Ginsberg MS; Jones DR
    Radiology; 2022 Jun; 303(3):664-672. PubMed ID: 35230187
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Solid predominant histologic subtype and early recurrence predict poor postrecurrence survival in patients with stage I lung adenocarcinoma.
    Luo J; Wang R; Han B; Zhang J; Zhao H; Fang W; Luo Q; Yang J; Yang Y; Zhu L; Chen T; Cheng X; Huang Q; Wang Y; Zheng J; Chen H
    Oncotarget; 2017 Jan; 8(4):7050-7058. PubMed ID: 27732964
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genomic mapping of metastatic organotropism in lung adenocarcinoma.
    Lengel HB; Mastrogiacomo B; Connolly JG; Tan KS; Liu Y; Fick CN; Dunne EG; He D; Lankadasari MB; Satravada BA; Sun Y; Kundra R; Fong C; Smith S; Riely GJ; Rudin CM; Gomez DR; Solit DB; Berger MF; Li BT; Mayo MW; Matei I; Lyden DC; Adusumilli PS; Schultz N; Sanchez-Vega F; Jones DR
    Cancer Cell; 2023 May; 41(5):970-985.e3. PubMed ID: 37084736
    [TBL] [Abstract][Full Text] [Related]  

  • 26. KRAS Mutation Is a Significant Prognostic Factor in Early-stage Lung Adenocarcinoma.
    Kadota K; Sima CS; Arcila ME; Hedvat C; Kris MG; Jones DR; Adusumilli PS; Travis WD
    Am J Surg Pathol; 2016 Dec; 40(12):1579-1590. PubMed ID: 27740967
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pathologic Subtypes of Lung Adenocarcinoma Brain Metastasis Is a Strong Predictor of Survival After Resection.
    Casteillo F; Guy JB; Dal-Col P; Karpathiou G; Pommier B; Bayle-Bleuez S; Fournel P; Vassal F; Forest F
    Am J Surg Pathol; 2018 Dec; 42(12):1701-1707. PubMed ID: 30222604
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Minor histological components predict the recurrence of patients with resected stage I acinar- or papillary-predominant lung adenocarcinoma.
    Liu W; Zhang Q; Zhang T; Li L; Xu C
    Front Oncol; 2022; 12():1090544. PubMed ID: 36620572
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic significance of adenocarcinoma in situ, minimally invasive adenocarcinoma, and nonmucinous lepidic predominant invasive adenocarcinoma of the lung in patients with stage I disease.
    Kadota K; Villena-Vargas J; Yoshizawa A; Motoi N; Sima CS; Riely GJ; Rusch VW; Adusumilli PS; Travis WD
    Am J Surg Pathol; 2014 Apr; 38(4):448-60. PubMed ID: 24472852
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic value of epidermal growth factor receptor mutations and histologic subtypes with lung adenocarcinoma.
    Motono N; Funasaki A; Sekimura A; Usuda K; Uramoto H
    Med Oncol; 2018 Jan; 35(3):22. PubMed ID: 29387978
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Does the histologic predominance of pathological stage IA lung adenocarcinoma influence the extent of resection?
    Ito H; Nakayama H; Murakami S; Yokose T; Katayama K; Miyata Y; Okada M
    Gen Thorac Cardiovasc Surg; 2017 Sep; 65(9):512-518. PubMed ID: 28593420
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinicopathologic and genomic features of high-grade pattern and their subclasses in lung adenocarcinoma.
    Ahn B; Yoon S; Kim D; Chun SM; Lee G; Kim HR; Jin Jang S; Sang Hwang H
    Lung Cancer; 2022 Aug; 170():176-184. PubMed ID: 35820357
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Solid predominant histology predicts EGFR tyrosine kinase inhibitor response in patients with EGFR mutation-positive lung adenocarcinoma.
    Yoshida T; Ishii G; Goto K; Yoh K; Niho S; Umemura S; Matsumoto S; Ohmatsu H; Nagai K; Ohe Y; Ochiai A
    J Cancer Res Clin Oncol; 2013 Oct; 139(10):1691-700. PubMed ID: 23974272
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A retrospective study of the relationship between the pathologic subtype and lymph node metastasis of lung adenocarcinomas of ≤3 cm diameter.
    Lin W; Huang M; Zhang Z; Chai T; Chen S; Gao L; Lin J; Kang M
    Medicine (Baltimore); 2020 Sep; 99(36):e21453. PubMed ID: 32898994
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comprehensive analyses unveil novel genomic and immunological characteristics of micropapillary pattern in lung adenocarcinoma.
    Huo Y; Sun L; Yuan J; Zhang H; Zhang Z; Zhang L; Huang W; Sun X; Tang Z; Feng Y; Mo H; Yang Z; Zhang C; Yu Z; Yue D; Zhang B; Wang C
    Front Oncol; 2022; 12():931209. PubMed ID: 35992814
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tumor cell proliferation (Ki-67) expression and its prognostic significance in histological subtypes of lung adenocarcinoma.
    Li Z; Li F; Pan C; He Z; Pan X; Zhu Q; Wu W; Chen L
    Lung Cancer; 2021 Apr; 154():69-75. PubMed ID: 33626488
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Integrating genetic mutations and expression profiles for survival prediction of lung adenocarcinoma.
    Song Y; Chen D; Zhang X; Luo Y; Li S
    Thorac Cancer; 2019 May; 10(5):1220-1228. PubMed ID: 30993904
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Positive EGFR mutation status is a risk of recurrence in pN0-1 lung adenocarcinoma when combined with pathological stage and histological subtype: A retrospective multi-center analysis.
    Ito M; Miyata Y; Tsutani Y; Ito H; Nakayama H; Imai K; Ikeda N; Okada M
    Lung Cancer; 2020 Mar; 141():107-113. PubMed ID: 32035371
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of Novel CD74-NRG2α Fusion From Comprehensive Profiling of Lung Adenocarcinoma in Japanese Never or Light Smokers.
    Kohsaka S; Hayashi T; Nagano M; Ueno T; Kojima S; Kawazu M; Shiraishi Y; Kishikawa S; Suehara Y; Takahashi F; Takahashi K; Suzuki K; Takamochi K; Mano H
    J Thorac Oncol; 2020 Jun; 15(6):948-961. PubMed ID: 32036070
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genetic and Immune Profiles of Solid Predominant Lung Adenocarcinoma Reveal Potential Immunotherapeutic Strategies.
    Dong ZY; Zhang C; Li YF; Su J; Xie Z; Liu SY; Yan LX; Chen ZH; Yang XN; Lin JT; Tu HY; Yang JJ; Zhou Q; Sun YL; Zhong WZ; Wu YL
    J Thorac Oncol; 2018 Jan; 13(1):85-96. PubMed ID: 29127022
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.